News | May 14, 2024
Sanofi India posts Q1 CY24 PAT at Rs. 136.6 Cr
Sanofi India has reported total income of Rs. 738.9 crores during the period ended March 31, 2024
Sanofi India has reported total income of Rs. 738.9 crores during the period ended March 31, 2024
Data showed that the primary endpoint of recurrence-free survival (RFS) met the pre-specified futility criteria
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
Dexamethasone Tablets USP, 1 mg had annual sales of US$ 1.8 mn in the United States (IQVIA MAT March 24)
Lupin updates on shipment of Mirabegron ER Tablets
Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024
These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more
Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024
Piramal Pharma has reported total income of Rs. 2,578.74 crores during the period ended March 31, 2024
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
Subscribe To Our Newsletter & Stay Updated
